In our country, acute or chronic HBV-related end-stage liver diseases serve as the main indication of the liver transplantation, which is likely to bring about the reinfection of HBV post-LT.
在我国，乙型肝炎病毒(HBV)相关的急慢性终末期肝病逐渐成为肝移植的主要适应症。
Conclusion Combined liver and intestinal transplantation is a feasible and effective optimal clinical choice for patients with irreversible intestinal failure and TPN-related liver damage.
结论肝小肠联合移植对肠衰竭合并全肠外营养所致肝功能损害病人，是可行、有效的治疗方法。
Methods From September 2000 to June 2001, we performed liver transplantation for 11 patients including living related liver transplantation (4) and 7 orthotopic liver transplantation (7).
方法本组肝移植11例，其中亲体肝移植4例，原位肝移植7例，均采用显微外科技术行肝动脉吻合。
Objective: to discuss the prevention of HBV recurrence on patients with HBV-related end-stage liver disease after orthotopic liver transplantation with different therapeutics.
目的：探讨不同方法预防乙肝病毒相关性终末期肝病患者肝移植后乙肝复发的临床疗效。
Objective: to discuss the prevention of HBV recurrence on patients with HBV-related end-stage liver disease after orthotopic liver transplantation with different therapeutics.
目的：探讨不同方法预防乙肝病毒相关性终末期肝病患者肝移植后乙肝复发的临床疗效。
应用推荐